香港股市 已收市

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
27.13-0.19 (-0.70%)
收市:04:00PM EDT
26.27 -0.86 (-3.17%)
收市後: 05:52PM EDT

Insmed Incorporated

700 US Highway 202/206
Bridgewater, NJ 08807
United States
908 977 9900
https://www.insmed.com

版塊Healthcare
行業Biotechnology
全職員工912

高階主管

名稱頭銜支付行使價出生年份
Mr. William H. Lewis J.D., M.B.A.President, CEO & Chairman1.29M6.48M1969
Ms. Sara M. Bonstein M.B.A.Chief Financial Officer684.18k1981
Mr. Roger Adsett M.B.A.Chief Operating Officer894.7k1969
Mr. John Drayton Wise M.B.A.Chief Commercial Officer750k
Dr. Martina Flammer M.B.A., M.D.Chief Medical Officer763.62k1964
Mr. Brian K. Kaspar Ph.D.Chief Scientific Officer1974
Eleanor BarisserAssociate Director of Investor Relations
Mr. Michael Alexander Smith J.D.Chief Legal Officer & Corporate Secretary1978
Mandy FaheyExecutive Director of Corporate Communications
Ms. S. Nicole Schaeffer M.B.A.Chief People Strategy Officer660.81k1.18M1968
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

公司管治

截至 2024年3月1日 止,Insmed Incorporated 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中:6;董事會:5;股東權利:9;現金賠償:5。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。